Abstract
The timely identification of infectious pre-symptomatic and asymptomatic cases is key towards preventing the spread of a viral illness like COVID-19. Early identification has been done through routine testing programs, which are indeed costly and potentially burdensome for individuals who should be tested with high frequency. A supplemental tool is represented by wearable technology, that can passively monitor and identify individuals at high risk, alerting them to take a test. We designed a Markov chain model and simulated a routine testing and a wearable testing strategy to estimate the number of tests required and the average number of days in which an individual is infectious and undetected. According to our model, with 2 test per month available, we have that the number of infectious and undetected days is 4.1 in the case of routine testing, while it decreases by 46% and 27% with a wearable testing strategy in the presence or absence of self-reported symptoms. The proposed parametric model can be used for different viral illnesses by tuning its parameters. It shows that wearable technology informing a testing strategy can significantly reduce the number of infectious days in which an individuals can spread the virus. With the same number of infectious days, by using wearables we can potentially reduce the number of required tests and the cost of the testing strategy.
Funder
National Center for Advancing Translational Sciences
Publisher
Public Library of Science (PLoS)
Reference25 articles.
1. CMS.gov, https://www.cms.gov/newsroom/press-releases/biden-harris-administration-requires-insurance-companies-and-group-health-plans-cover-cost-home 2022.
2. Wearable sensor data and self-reported symptoms for COVID-19 detection;G Quer;Nature Medicine,2021
3. A method for intelligent allocation of diagnostic testing by leveraging data from commercial wearable devices: a case study on COVID-19.;MMH Shandhi;npj Digital Medicine.,2022
4. Pre-symptomatic detection of COVID-19 from smartwatch data;T Mishra;Nature Biomedical Engineering,2020
5. Assessment of physiological signs associated with COVID-19 measured using wearable devices.;A Natarajan;npj Digital Medicine.,2020